Companies Dominating the Epilepsy Landscape
-
- Stryker B.V.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Johnson & Johnson Services, Inc.
- Novartis AG
- Pfizer, Inc.
- Sunovion Pharmaceuticals, Inc.
- Sanofi aventis Group
- Koninklijke Philips N.V.
- Eisai Co. Ltd.
- Cephalon, Inc.
- Abbott Laboratories
- Stryker B.V.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Epilepsy Market in 2025 is estimated at USD 721.75 million.
The global market size was over USD 681.41 million in 2024 and is anticipated to witness a CAGR of around 7.4%, crossing USD 1.72 billion revenue by 2037.
North America is projected to achieve largest share by 2037, attributed to increasing prevalence of epilepsy, a strong healthcare network, and supportive regulatory policies in the region.
The major players in the market include Stryker B.V., Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., Sunovion Pharmaceuticals, Inc., Sanofi aventis Group, Koninklijke Philips N.V., Eisai Co. Ltd., Cephalon, Inc., Abbott Laboratories.
